Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Drugs are usually biotransformed into new chemical species that may have either toxic or therapeutic effects. Drug metabolism studies are routinely performed in laboratory animals but, due to metabolic interspecies differences when compared to man, they are not accurate enough to anticipate the metabolic profile of a drug in humans. Human hepatocytes in primary culture provide the closest in vitro model to human liver and the only model that can produce a metabolic profile of a given drug that is very similar to that found in vivo. However their availability is limited due to the restricted access to suitable tissue samples. The scarcity of human liver has led to optimising the cryopreservation of adult hepatocytes for long-term storage and regular supply. Human hepatocytes in primary culture express typical hepatic functions and express drug metabolising enzymes. Moreover, qualitative and quantitative similarities between in vitro and in vivo metabolism of drugs were observed. Different strategies have been envisaged to prolong cell survival and delay the spontaneous decay of the differentiated phenotype during culture. Thus, hepatocytes represent the most appropriate model for the evaluation of integrated drug metabolism, toxicity/metabolism correlations, mechanisms of hepatotoxicity, and the interactions (inhibition and induction) of xenobiotics and drug-metabolising enzymes. However, in view of limitations of primary hepatocytes, efforts are made to develop alternative cellular models (i.e. metabolic competent CYP-engineered cells stably expressing individual CYPs and transient expression of CYPs by transduction of hepatoma cells with recombinant adenoviruses). In summary, several cellular tools are available to address key issues at the earliest stages of drug development for a better candidate selection and hepatotoxicity risk assessment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, liverspecific functions of primary hepatocytes relevant for drug development and toxicity studies are rapidly downregulated during their in vitro cultures [57].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [57]
In the citing paper
“Immortalized cell lines can be used in most research instead of primary cells because they offer several advantages, including cost-effectiveness, ease of use, unlimited availability of materials, and the bypassing of ethical concerns associated with animal and human tissue use [14,15,16].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [14]
Citations
Cites
Progress in the reduction, refinement and replacement of animal experimentation
Balls, M., van Zeller, A.-M., & Halder, M. (2000) · DigitalGeorgetown (Georgetown University Library) · Cited by 296
Isolation, Culture and Use of Human Hepatocytes in Drug Research
Gómez-Lechón, M. J., Donato, M. T., Ponsoda, X., Fabra, R., Trullenque, R., & Castell, J. V. (1996) · Elsevier eBooks · doi:10.1016/b978-012163390-5.50007-7 · Cited by 53
Self-citation
Cited by
Items 201–272 of 272
Subbaiah, M. A. M., Surendran, S., Saini, G., Ramappa, L. B., Raju, S., Nandha, J., Bhowmik, H., Krishna, E. H., Janrao, S., Kumar, V. A., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03656 · Cited by 3
Toxicogenomic Study of Triazole Antifungal Modes of Action
Goetz, A. K. (2007) · NCSU Libraries Repository (North Carolina State University Libraries) · Cited by 3
Carbon Black CB-EDA Nanoparticles in Hepatocytes: Changes in the Oxidative Stress Pathway
Rodolpho, J. M. D. A., de Godoy, K. F., Brassolatti, P., Fragelli, B. D. D. L., Camillo, L., de Castro, C. A., Nogueira, C. T., Biotechnology, P. I., Assis, M., Speglich, C., et al. (2022) · International Journal of Pharmaceutical and Bio-Medical Science · doi:10.47191/ijpbms/v2-i12-16 · Cited by 3
Schmitmeier, S., Langsch, A., Schmidt‐Heck, W., Jasmund, I., & Bader, A. (2007) · Journal of Membrane Science · doi:10.1016/j.memsci.2007.04.006 · Cited by 3
Paixão, P. J. P. A. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 3
Hartauer, M., Ho, H. S. S., Wan, M., Murphy, W. A., Tiley, J. B., Fallon, J. K., Bishop, C. E., & Brouwer, K. L. R. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05996-z · Cited by 2
Single-cell transcriptomics of acetaminophen-induced responses in human 2D and 3D liver microtissues
Bwanya, B., Verheijen, M. C. T., Hauser, D. A., de Kok, T. M. C. M., Jennen, D. G. J., van den Beucken, T., & Caiment, F. (2026) · Archives of Toxicology · doi:10.1007/s00204-025-04296-6 · Cited by 2
Gao, X., Yourick, J. J., & Sprando, R. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823884-4.00003-1 · Cited by 2
Cell line studies in Ayurveda: Bridging ancient wisdom and modern science
Sebastian, T. (2024) · International Journal of Biological and Pharmaceutical Sciences Archive · doi:10.53771/ijbpsa.2024.7.1.0030 · Cited by 2
Aplicación de la farmacogenómica y otras nuevas tecnologías al desarrollo de medicamentos
Cabaleiro, T., Prieto‐Pérez, R., Ochoa, D., & Abad‐Santos, F. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.02.010 · Cited by 2
Drug Interactions with St. John's Wort
Krasowski, M. D., & Blau, J. (2010) · Wiley eBooks · doi:10.1002/9780470910108.ch12 · Cited by 2
Li, A. P. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_9 · Cited by 2
Drug metabolism in human and rat intestine: an 'in vitro' approach
van de Kerkhof, E. G. (2007) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Risk and benefit : analysis of herbal products from Indonesia
Suparmi, S. (2020) · doi:10.18174/512309 · Cited by 2
Bernardini, C., & Nauwelaerts, N. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.5825333 · Cited by 2
Influencia de los factores del donante en el aislamiento y cultivo de hepatocitos humanos
Martínez Blasco, M. A. (2012) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 2
Molecular characterization of breast cancer cell lines in correlation with clinical markers
Kashyap, D., & Salman, H. (2023) · Open Journal of Clinical and Medical Images · doi:10.52768/2833-2725/1186 · Cited by 1
High-yield isolation of primary human hepatocytes from small liver samples
Guy, T., Ruan, J.-L., Lee, C., Purdie, K., Johnson, D. R., Gordon-Weeks, A. N., & Nanchahal, J. (2025) · In vitro models · doi:10.1007/s44164-025-00097-4 · Cited by 1
Piryaei, A., Valoujerdi, M. R., Shahsavani, M., & Baharvand, H. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
In vitro investigation of drug metabolism and toxicity in man
Lechón-Moliner, M. J. G., & Donato, M. T. (2007) · Anales de la Real Academia Nacional de Farmacia · Cited by 1
Self-citationPang, Y., Sutoko, S., Horimoto, Y., Anzai, M., Niino, T., & Sakai, Y. (2015) · 生産研究 · doi:10.11188/seisankenkyu.67.259 · Cited by 1
Bio-inspired Toxicity Assay Based on Xenobiotic Metabolism
Rodríguez, Á. (2012) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Fedaruk, D. A., Кирковский, Л. В., Садовский, Д. Н., Petrenko, K. I., Lebed, O. A., Fedaruk, A., & Руммо, О. О. (2020) · Hepatology and Gastroenterology · doi:10.25298/2616-5546-2020-4-1-28-33 · Cited by 1
Induction and inhibition of cytochrome P-450*
Pelkonen, O. (2004) · Monografías de la Real Academia Nacional de Farmacia · Cited by 1
Fasinu, P. S. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
Müller, J. (2008) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1428 · Cited by 1
Redlich, G. (2008) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · Cited by 1
Dumont, C. (2010) · theses.fr (ABES) · doi:10.70675/b56fad23z6591z419dz80e0zea27cae1610c · Cited by 1
Morgan, A. D. (2015) · Scholarship@Western (Western University)
The development of a novel in vitro model of human liver for the study of disease pathogenesis
Li-qiong, C. (2010) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Hammersen, J. F. (2011) · Qucosa (Saxon State and University Library Dresden)
In vitro investigations on uptake and toxicity of cyanobacterial toxins
Fischer, A. (2010) · KOPS (University of Konstanz)
Process engineering of liver cells for drug testing applications
Tostões, R. M. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Klis, G. (2009) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-2025
Applying Pluripotent Stem Cell Technology to Modelling Human Liver Disease
Hannan, N. R. F., Rashid, S. T., & Vallier, L. (2012) · Science Publishers eBooks · doi:10.1201/b11937-6
Use of Stem Cells in Toxicology
Matz, P., Spitzhorn, L., Otte, J., Kawala, M.-A., Woestmann, J., Yigit, H., Wruck, W., & Adjaye, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12380-7
Valkonen, M. (2013) · Helda - University of Helsinki Institutional Repository
Synthesis and Evaluation of Tetrahydroprotoberberines as Dopamine Receptor Ligands
Gadhiya, S. (2017) · CUNY Academic Works (City University of New York)
Alomari, M. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-78101-9_6
In Vitro Inhibition Of Herbal Constituents On Ugt2b7 Enzyme Activity
Abdullah, N. H. (2018) · Universiti Sains Malaysia Institutional Repository (Universiti Sains Malaysia)
Han, X. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/311
Introduction to animal tissue culture science
Khan, M. R., Asaduzzaman, M., Bhatia, S., & Al‐Harrasi, A. (2024) · Institute of Physics eBooks · doi:10.1088/978-0-7503-5392-2ch1
Legrand, A.-F. (2023) · theses.fr (ABES) · doi:10.70675/aa41850ezf624z48d3zbccaz86f57d070bc3
Oral insulin delivery—Challenges and strategies
Sonia, T. A., & Sharma, C. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30272-5.00012-3
Συστημική μοντελοποίηση muti-omics δεδομένων για εύρεση μηχανισμών ανθρώπινων ασθενειών
Zareifi, D.-S. (2022) · DSpace - NTUA (National Technical University of Athens) · doi:10.26240/heal.ntua.22425
Effects of multiple stressors on DNA damage occurrence
Germ, K. E. (2014) · ThinkTech (Texas Tech University)
Synthesis and analysis of potential metabolites of ADB-5´Br-BUTINACA
Malekshahineia, A. (2023) · DiVA (Digitala Vetenskapliga Arkivet)
Mendiara Negredo, I., de la Puerta, C. N., & Domeño Recalde, C. (2018) · Zaguan (Universidad de Zaragoza)
Cirugía de ojo seco y cataratas
Ipek, T. (2020) · Library Open Repository (Universidad Complutense Madrid)
Eucaryotic cells systems and their biotechnologycal applications
Porubiaková, O. (2021) · Brno University of Technology Digital Library (Brno University of Technology)
Cellular Models for Liver Toxicity: keeping track of time
de Wit, A. S. (2014) · RePub (Erasmus University Rotterdam)
Ousji, O. (2023) · Archipel (Université du Québec à Montréal)
Predapoptotski celični odziv na stres v primarnih hepatocitih
Miller, I. P. (2023) · Repository of the University of Ljubljana (University of Ljubljana)
A 3D hepatic model to address immune‐mediated drug hepatotoxicity
Oliveira, J. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Zhang, Y., Han, X., Wu, J., Liu, S., Zhang, H., Zhao, L., & Li, G. (2026) · Marine Drugs · doi:10.3390/md24010030
Smimih, K., El‐Mansoury, B., Marghich, M., Azzouhri, C., Zouhairi, N., Agnaou, M., Guennouni, M., Fdil, N., Bitar, A., Abulmeaty, M. M. A., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1742806
Différenciation des cellules souches embryonnaires humaines vers l'hépatocyte
Funakoshi, N. (2011) · theses.fr (ABES) · doi:10.70675/124c2d82za8a6z4426zaff0z873bdb00a1fa
Etudes pharmacologiques d'un modèle cellulaire 2D/3D dans le cancer hépato-pancréatique
Hassan, S. (2018) · theses.fr (ABES) · doi:10.70675/caad66fazc89dz40bbz9d41z6f9c29c4e2c9
Djuari, M. A., Londenberg, A., Bassan, A., Cross, K. P., Elenschneider, L., Escher, S. E., Fahrer, J., Fangmann, J., Felske, C., Frötschl, R., et al. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04457-1
Bing, G.-H., Kwon, C.-Y., Lee, H., & Lee, Y.-J. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00819-0
Multitask learning in predictive toxicology: methods, benchmarks, and applications
Hong, H., Liu, J., Guo, W., & Patterson, T. A. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2725245
Chaphekar, N., Joshi, A., Caritis, S. N., Kandasamy, M., Venkataramanan, R., & Shaik, I. H. (2026) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-026-01031-z
Shrestha, A. P., Mathur, S., Duarte, S. M., & Zarrinpar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00020-0
Effects of pharmaceuticals in fish : in vitro and in vivo studies
Corcoran, J. (2013) · OpenGrey (Institut de l'Information Scientifique et Technique)
Derivations of Tissue Slice Technology as Toxicological Screening Systems
Catania, J. M. (2006) · UA Campus Repository (The University of Arizona)
Metadata
- Authors
- Gomez-Lechon, M., Donato, M., Castell, J., & Jover, R.
- Affiliations
- Hospital Universitari i Politècnic La Fe (ES)
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-08-01
- Volume
- 4
- Issue
- 4
- Pages
- 292-312
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2112247582
- Cited by
- 242
- References
- 2
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 18 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 16 · 2012: 12
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- human hepatocytes, primary hepatocyte culture, drug metabolism, hepatotoxicity, toxicity prediction, drug-metabolizing enzymes, adenoviral transduction, hepatoma cells, xenobiotic interactions, in vitro-in vivo correlation, drug development
- MeSH terms
- Cells, Cultured, Cytochrome P-450 Enzyme System, Drug Interactions, Pharmaceutical Preparations, Humans, Liver, Models, Biological, Time Factors, Hepatocytes, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.